Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 13, 2013Diabetes Obesity and MetabolismOpen Access

Dapagliflozin a glucose‐regulating drug with diuretic properties in subjects with type 2 diabetes

View Full Paper
Ask AI
Bookmark
Share

Authors

Hiddo J.L. Heerspink
Hiddo J.L. HeerspinkPreventive Cardiology
Dick de Zeeuw
Dick de ZeeuwPreventive CardiologyLWLi WieZhejiang Chinese Medical University

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Heerspink et al. (2013) studied this question.

synapsesocial.com/papers/69d7f43ea2a48916bbbee7f8https://doi.org/10.1111/dom.12127
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Effect of Noninsulin Antidiabetic Drugs Added to Metformin Therapy on Glycemic Control, Weight Gain, and Hypoglycemia in Type 2 Diabetes2010 · 525 citations
  2. 2Dapagliflozin, a Novel, Selective SGLT2 Inhibitor, Improved Glycemic Control Over 2 Weeks in Patients With Type 2 Diabetes Mellitus2009 · 398 citations
  3. 3Effects of Dapagliflozin on Body Weight, Total Fat Mass, and Regional Adipose Tissue Distribution in Patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on Metformin2012 · 877 citations
  4. 4Comparison of Fixed-dose Rosiglitazone/Metformin Combination Therapy with Sulphonylurea Plus Metformin in Overweight Individuals with Type 2 Diabetes Inadequately Controlled on Metformin Alone2007 · 49 citations
  5. 5A Simple Method for the Determination of Glomerular Filtration Rate1972 · 897 citations